Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Auddia Announces Pricing of $3.1 Million Registered Direct Offering of Common Stock Priced At-The-Market
-
Virpax Pharmaceuticals to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
-
Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
-
Citius Pharmaceuticals to Participate in Maxim Group's Virtual Healthcare Conference on June 21, 2023
-
SELLAS to Participate in Maxim Group Healthcare Virtual Conference
-
IceCure Medical to Review Recent Progress at Maxim Group's Virtual Healthcare Conference
-
Alzamend Neuro CEO Stephan Jackman to Participate on the “Mental Health, More Critical Than Ever” Panel at the Maxim Group’s Virtual Healthcare Conference
-
Zevra Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
-
Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference
-
Aytu BioScience (AYTU) Prices $4M Share Offering
-
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
-
Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference
-
Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023
-
Heart Test Laboratories (HSCS) Announces 8M Share Offering
-
Kustom Entertainment, Inc. Enters into Business Combination Agreement with Clover Leaf Capital Corp.
-
Trust Stamp (IDAI) Prices 1.28M Share Offering at $2.30/sh
-
Trust Stamp Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
-
LogicMark to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 1st
-
Horizon Technology Finance (HRZN) prices 3.25 million share offering at $12.50/share
-
Horizon Technology Finance Corporation Prices Public Offering of Common Stock
-
Cloud DX to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 1st at 9:00 A.M. ET
-
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
Reliq Health Technologies, Inc. to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and Hosted by M-Vest, June 1st, 2023
-
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
-
Biocept (BIOC) Prices 1.18M Share Offering at $4.25/sh
-
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
-
Biolase (BIOL) Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes $2 Million Public Offering Consisting of Common Shares and Accompanying Warrants
-
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023
-
mCloud Technologies (MCLD) Provides Update from Special Committee Exploring Strategic Alternatives
-
mCloud Provides Update from Special Committee Exploring Strategic Alternatives
-
Applied UV Reports Q1, 2023 Financial Results
-
Daxor Corp. (DXR) Prices 410K Share Offering at $9.75/sh
-
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
-
Daxor Corp. (DXR) Announces Proposed Stock Offering, Size not Disclosed
-
Daxor Corporation Announces Proposed Underwritten Public Offering
-
Augmedix Announces Participation in Upcoming Investor Conferences
-
SunCar (SDA) Completes Business Combination with Goldenbridge Acquisition Limited (GBRG) to Become Publicly Traded Company
-
SunCar Completes Business Combination with Goldenbridge Acquisition Limited to Become Publicly Traded Company
-
Acurx Pharmaceuticals (ACXP) Prices 1.33M Share Offering at $3/sh
-
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) - Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) - Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Maxim Research Update: Society Pass (Nasdaq: SOPA) – Compelling Valuation; 1Q23 EBITDA Beats Forecast
-
Ocean Biomedical (OCEA) Enters $25M Convertible Note Facility
-
Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility
-
SAI.TECH to Participate in the Bitcoin Mining Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, May 16th at 9:00 A.M. ET
-
FCM Director Nominees Will Put MindMed Drug Development Process Back on Track
-
Canaan Inc. to Participate in the Bitcoin Mining Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, May 16, 2023

